Unable to view this mail? Please click here to view in browser
Vertical_Talk Healthcare Growing Pharma market in Southeast Asia
Pharmacovigilance regulations
Late-phase clinical and commercial production
The Future of Generic Drugs
e-Newsletter www.pharmafocusasia.com | Archives | Advertise


Auven Therapeutics Announces Sale of Ocular Technologies to Sun Pharma

EpiPen rival plans return to U.S. market in first-half 2017

Horizon Pharma plc Completes Acquisition of Raptor Pharmaceutical Corp.

Press Releases

Ra Pharmaceuticals Announces Pricing of Initial Public Offering

Entasis Announces Initiation of Phase I Clinical Trial of ETX2514

Apricus Biosciences Announces Approval of Vitaros® for the Treatment of Erectile Dysfunction in Greece

01 -02 Nov 2016
Digital Pathology Congress Middle East

03 -04 Nov 2016
Pathology Update 2016

03 -05 Nov 2016
12th Nanotechnology Products Expo 2016

08 -10 Nov 2016
Extractables and Leachables Europe 2016


Untapped Opportunities in Southeast Asia
Sue Lee
Technical Portfolio Manager, World Courier

Southeast Asia is a growing pharmaceutical market with an increase in clinical trials in recent years. With a population of about 620 million and a total area of 4.5 million kilometres it contains the region’s well-recognised study destinations of Malaysia...

State of Pharmacovigilance
Giovanni Furlan
EU QPPV, Helsinn Birex Pharmaceuticals, Ireland

In recent years there has been a proliferation of pharmacovigilance guidelines and regulations. Regulatory authorities have implemented different requirements, templates and regulations, and some of them have asked pharmaceutical companies...


Catalent Pharma Solutions Plans $34 Million Expansion Of Biologics Manufacturing Facility in Madison, Wisconsin

Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, plans for a new $34 million extension to its state-of-the-art Madison, Wisconsin biologics manufacturing facility...

Glioblastoma Multiforme – Cancer Immunotherapies Dominate First-in-Class...

The Future of Generic Drugs and Strategies for Commercial Success

Type 2 Diabetes Mellitus Therapeutics in South-East Asia Markets to 2022...

Current Issue
Current Issue
Editorial Calender
Media Pack
e-Magazine| Subscribe | Unsubscribe Pharma Focus Asia
www.pharmafocusasia.com – Owned by Ochre Media Pvt. Ltd.
Media Resource Centre,2nd Floor, Oxford Plaza, Secunderabad - 500 003, Telangana, India
Tel: +91 40 4961 4567 | Fax: +91 40 4961 4555